Canadian researchers insist Pfizer’s 1st dose effective enough to delay 2nd

The second dose of Pfizer Inc’s COVID-19 vaccine could be delayed in order to cover all priority groups as the first one is highly protective, two Canada-based researchers said in a letter published in the New England Journal of Medicine.

The vaccine had an efficacy of 92.6 per cent after the first dose, Danuta Skowronski and Gaston De Serres said, based on an analysis of the documents submitted by the drugmaker to the U.S. Food and Drug Administration (FDA).

Read more: Israel reports 94% drop in symptomatic COVID-19 cases with Pfizer vaccine, study shows

These findings were similar to the first-dose efficacy of 92.1 per cent reported for Moderna Inc’s mRNA-1273 vaccine, according to the letter on Wednesday.

In its response, Pfizer said alternative dosing regimens of the vaccine had not been evaluated yet and that the decision resided with the health authorities.

Story continues below advertisement

Some countries, grappling with low supplies, are looking at dosing patterns or volumes that differ from how the vaccines were tested in clinical trials.

Coronavirus: U.K. trial to test combining Pfizer, AstraZeneca vaccines in 2-shot regimen

Coronavirus: U.K. trial to test combining Pfizer, AstraZeneca vaccines in 2-shot regimen – Feb 4, 2021

There are differences over the merits of such strategies, with some arguing the urgency of the pandemic requires flexibility, while others oppose abandoning data-driven approaches for the sake of expediency.

Skowronski and De Serres cautioned that there may be uncertainty about the duration of protection with a single dose, but said the administration of the second dose a month after the first provided “little added benefit in the short term.”

Skowronski works at the British Columbia Centre for Disease Control, while De Serres is from the Institut National de Santé Publique du Québec

Read more: Health Canada expected to change Pfizer doses from 5 to 6 — but is that reasonable?

Health Canada expected to change Pfizer doses from 5 to 6 — but is that reasonable? – Jan 28, 2021